Scynexis (SCYX) Operating Margin Growth (5y) (2018 - 2024)
Scynexis (SCYX) Operating Margin Growth (5y) (2018 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Scynexis | 62.02 Mn | -52.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 1.84 Mn |
| Mar 31, 2024 | 1.78 Mn |
| Dec 31, 2023 | 1.33 Mn |
| Sep 30, 2023 | 927,345.00 |
| Jun 30, 2023 | 1.21 Mn |
| Mar 31, 2023 | 1.04 Mn |
| Dec 31, 2022 | 971,393.00 |
| Sep 30, 2022 | 859,824.00 |
| Jun 30, 2022 | 889,598.00 |
| Mar 31, 2022 | 658,029.00 |
| Dec 31, 2021 | 492,824.00 |
| Sep 30, 2021 | 671,049.00 |
| Mar 31, 2021 | 1.13 Mn |
| Jun 30, 2019 | -1.35 Mn |
| Mar 31, 2019 | -1.85 Mn |
| Dec 31, 2018 | -1.38 Mn |
| Sep 30, 2018 | -976,093.00 |
| Jun 30, 2018 | -1.19 Mn |
| Mar 31, 2018 | -1.13 Mn |